CAT No: N1101
CAS No:3106-85-2
Synonyms/Alias:spaglumic acid;Isospaglumic acid;3106-85-2;NAAG;N-Acetyl-Asp-Glu;N-Acetylaspartylglutamic acid;N-acetylaspartylglutamate;Acido isospaglumico;Acide isospaglumique;NAAGA;Isospaglumic acid [INN];N-Acetyl-L-aspartyl-L-glutamic acid;Acidum isospaglumicum;1W8M12WXYL;Acide isospaglumique [French];Acido isospaglumico [Spanish];Acidum isospaglumicum [Latin];(S)-2-((S)-2-Acetamido-3-carboxypropanamido)pentanedioic acid;L-Glutamic acid, N-acetyl-L-alpha-aspartyl-;MFCD00076652;(2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]pentanedioic acid;N-Acetyl-1-aspartylglutamic acid;CHEBI:73688;N-acetylaspartylglutamate (NAAG);ISOSPAGLUMIC ACID [MART.];N-(N-Acetyl-L-alpha-aspartyl)-L-glutamic acid;ISOSPAGLUMIC ACID [WHO-DD];N-acetyl-L-alpha-aspartyl-L-glutamic acid;Acidum isospaglumicum (Latin);Ac-Asp-Glu-OH;N-(N-ACETYL-L-.ALPHA.-ASPARTYL)-L-GLUTAMIC ACID;ISOSPAGLUMIC ACID (MART.);NAAGA sodium salt;N-acetyl-1-Asp-Glu;SR-01000597665;UNII-1W8M12WXYL;spaglumic-acid;N-Acetyl-alpha-aspartylglutamic acid;N-acetyl-aspartyl-glutamic acid;(2S)-2-(((2S)-2-acetamido-3-carboxypropanoyl)amino)pentanedioic acid;a-Spaglumic acid;Ac-Asp-Glu;Zy15109;alpha-Spaglumic acid;N-acetyl-L-alpha-aspartylglutamic acid;ZY15106;Spectrum_000399;Tocris-0391;L-Glutamic acid, N-acetyl-L-a-aspartyl-;ZY 15106;N-acetyl-L-Asp-L-Glu;Prestwick0_001091;Prestwick1_001091;Prestwick2_001091;Spectrum2_001571;Spectrum3_000759;Spectrum4_000873;Spectrum5_001840;N-Ac-D-E;[3H]NAAG;BSPBio_002378;BSPBio_003230;KBioGR_001565;KBioSS_000879;2-[(2-acetamido-3-carboxy-1-oxopropyl)amino]pentanedioic acid;DivK1c_000662;SCHEMBL288514;SPECTRUM1503630;SPBio_001502;SPBio_003051;GTPL1405;Acetyl-a-L-aspartylglutamic acid;CHEMBL1329032;DTXSID3091535;Isospaglumic acid;Spaglumic Acid;n-acetyl-a-aspartylglutamic acid;BDBM17658;HMS502B04;KBio1_000662;KBio2_000879;KBio2_003447;KBio2_006015;KBio3_001598;NINDS_000662;HMS1571K04;HMS3411I03;HMS3675I03;N-(N-Acetylaspartyl)glutamic acid;Pharmakon1600-01503630;Acetyl-alpha-L-aspartylglutamic acid;CCG-38888;NSC758468;(2S)-2-[[(2S)-2-acetamido-4-hydroxy-4-oxobutanoyl]amino]pentanedioic acid;AKOS024457865;FA05316;N-Acetyl-a-L-aspartyl-L-glutamic acid;SDCCGMLS-0066696.P001;IDI1_000662;NCGC00016651-01;NCGC00016651-02;NCGC00024569-01;NCGC00024569-02;AS-76948;N-Acetyl-alpha-L-aspartyl-L-glutamic acid;SBI-0052840.P002;HY-100921;CS-0020591;NS00007578;C15544;AB00053333_02;Q2394106;SR-01000597665-1;SR-01000597665-2;BRD-K68405354-001-06-4;BRD-K68405354-001-07-2;(2S)-2-[(3S)-3-acetamido-3-formamidopropanoic acid]pentanedioic acid;635-744-0;
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More